Landec Corporation Sets Second Quarter Fiscal Year 2016 Conference Call for January 6, 2016 at 8 a.m. PT and Earnings Release Set for January 5, 2016 After Market

MENLO PARK, Calif., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Landec Corporation LNDC will hold a conference call on Wednesday, January 6, 2016 at 8 a.m. Pacific time to discuss its results for the second quarter fiscal 2016. Financial results will be reported for the 2016 fiscal second quarter ended November 29, 2015 after market close on January 5, 2016.

Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.

Date: Wednesday, January 6, 2016
Time: 8 a.m. Pacific time (11 a.m. Eastern time)  
Toll Free Participant Dial-in Number: 866-814-1914  
U.S. and International Toll Number: 703-639-1358
Conference ID: 1667127

Webcast: www.Landec.com/earningscall
The webcast will be available for 30 days through February 5, 2016.

A replay of the teleconference will be available for one week until midnight Eastern Time, Wednesday, January 13, 2016.

Toll free replay dial in: 888-266-2081
International replay: 703-925-2533 
Replay passcode: 1667127 

About Landec Corporation

Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets.  Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology and the strength of two major national brands, Eat Smart® and GreenLine®, with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP (current good manufacturing practices) validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements. For more information about the company, visit Landec's website at www.landec.com.